# Myopia Intervention in Children and Adolescents and Establishment of a Precise Intervention Model

> **NCT05357326** · PHASE4 · UNKNOWN · sponsor: **Shanghai Eye Disease Prevention and Treatment Center** · enrollment: 186 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Atropine Sulfate 0.01% Eye Drop
- **DEVICE:** Orthokeratology
- **DRUG:** Atropine Sulfate 0.04% Eye Drop

## Key facts

- **NCT ID:** NCT05357326
- **Lead sponsor:** Shanghai Eye Disease Prevention and Treatment Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-08-31
- **Target enrollment:** 186 (ESTIMATED)
- **Last updated:** 2022-05-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05357326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05357326, "Myopia Intervention in Children and Adolescents and Establishment of a Precise Intervention Model". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05357326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*